Purpose Diabetic patients have a high risk for cardiovascular events. The role of myocardial perfusion imaging was investigated in asymptomatic diabetic patients to evaluate short-term prognosis in a Japanese population. Methods A total of 506 asymptomatic patients ≥50 years of age who had carotid artery maximum intima-media thickness ≥1.1 mm, urinary albumin excretion of ≥30 mg/g creatinine, with additional criteria of abdominal obesity, low HDL cholesterol, high triglyceride level, and hypertension were enrolled and followed up over a 3-year period. Gated SPECT with stress-rest protocol was performed and analyzed by summed defect scores and QGS software. Oneyear cardiovascular events were analyzed. Results Myocardial ischemia was observed in 17% of patients, and abnormal perfusion findings of ischemia and/or scar were observed in 32% of patients. By the end of the 1-year follow-up, 33 (6.5%) cardiovascular events occurred including 6 all-cause deaths. Patients with summed stress score (SSS) >8 had a higher incidence of either death or cardiovascular events. Event-free survival rates for SSS 0-3, 4-8, 9-13, and ≥14 were 0.96, 0.95, 0.82, and 0.76, respectively. Multivariate Cox regression analysis showed that significant variables were SSS, history of cerebrovascular accident, and electrocardiographic abnormality at rest. Conclusion The 1-year interim summary showed that cardiovascular events were significantly higher in patients with SPECT abnormality, although hard cardiac event rate was relatively low. Targeted treatment strategy is required for asymptomatic but potentially high-risk diabetic patients.
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Introduction
For risk stratification of ischemic heart events, coronary stenosis, myocardial ischemia, and baseline cardiac functions are important factors to predict patient prognosis. Various clinical conditions including metabolic syndrome have been investigated using myocardial perfusion imaging (MPI) [1] . Among the clinical backgrounds, diabetes mellitus promotes atherosclerosis, resulting in one of the major pathophysiological causes of cerebral infarction and myocardial infarction [2] [3] [4] . The risk of patients with diabetes is two-to fourfold higher than nondiabetic patients and is comparable with those with prior myocardial infarction [5, 6] . Since atherosclerosis may progress even in asymptomatic diabetic patients, it is vital to diagnose ischemic heart diseases at an early subclinical stage [7] [8] [9] .
The role of MPI for detecting ischemia has been validated well and supported by many precedent single photon emission computed tomography (SPECT) studies [10] [11] [12] [13] . A general consensus has been achieved for detection of ischemia and prognostic evaluation [3, 14] . Although abundant data are available in Western countries, few data are available dealing with the role of MPI in Japanese nondiabetic and diabetic patients. In a Japanese prognostic cohort study using gated SPECT (J-ACCESS study), the hard event rate was relatively lower than that in Western prognostic studies [6, 15] . We therefore began the J-ACCESS 2 prospective cohort study with a 3-year followup period that focused on asymptomatic patients with type 2 diabetes.
We hypothesized that gated MPI has prognostic value to predict cardiovascular events even in a short-term followup. The incidences of stress-induced ischemia and resting perfusion defect, as well as functional abnormalities by gated MPI, were summarized in asymptomatic patients with type 2 diabetes, and the prognostic value was investigated during a 1-year follow-up period.
Materials and methods

Patients
The J-ACCESS 2 prognostic registry was a prognostic cohort study involving 513 patients from 50 institutions [16] . The registration period was from June 2004 through September 2005. All institutions employed certified physicians for diabetes and could participate in a 3-year follow-up after registration. The inclusion criteria included patients with type 2 diabetes, ≥50 years of age, who either had a maximal carotid artery intima-media thickness (IMT max ) ≥1.1 mm by ultrasonography or a urinary albumin excretion rate of ≥30 mg/g creatinine, or patients who satisfied at least two of the following four conditions: abdominal obesity [body mass index (BMI) ≥25 and waist circumference ≥85 cm for men and ≥90 cm for women], hypo-HDL-cholesterolemia (<40 mg/dl), hypertriglyceridemia (≥150 mg/dl), and hypertension (blood pressure ≥130/ 85 mmHg) (Fig. 1) . The criteria of waist circumference were in accordance with Japanese guidelines [17, 18] . Exclusion criteria included patients with myocardial infarction, effort angina, and unstable angina. Patients with hemoglobin A 1c (HbA 1c ) ≥10% or evidence of nephropathy (serum creatinine ≥1.5 mg/dl) within 1 month before enrollment were excluded. Also excluded were patients with valvular heart disease, idiopathic cardiomyopathy, evidence of rest ECG abnormalities such as atrial fibrillation, New York Heart Association class III or IV heart failure at the time of myocardial perfusion SPECT, and arteriosclerosis obliterans. A total of 83% of patients were medically treated, and the remaining patients were controlled by diet, exercise, etc. at the time of registration.
The Institutional Review Board of each hospital approved the study, and the whole study was conducted in compliance with the Ethical Guidelines for Epidemiological Research in Japan. Written informed consent was obtained from all participants.
Myocardial perfusion imaging
Stress-rest MPI was performed with 99m Tc-tetrofosmin. A 1-day protocol was used in 94% of the institutions and a 2-day protocol in the remaining institutions. Regarding the stress types, exercise, dipyridamole (0.15 ml/min per kg × 4 min), adenosine (0.12 ml/min per kg × 6 min), and adenosine triphosphate (0.16 ml/min per kg × 5 min) were performed in 72, 16, 6 , and 6% of the institutions, respectively. The average dose of 99m Tc-tetrofosmin administered was 331 MBq for the initial study and 748 MBq for the second study. The exercise study was performed at 36±20 min after tetrofosmin injection, and the resting study was similarly performed at 47±20 min after injection. The interval between the stress and rest studies was 60-120 min. A gated study was performed at least at rest. SPECT imaging was performed with standard acquisition protocols with 360 or 180°rotations. Gating was performed by 16, 8, 12 , and 32 frames per cardiac cycle in 44, 40, 12, and 4% of the institutions. According to the preceding J-ACCESS substudy in patients with low likelihood of ischemic heart disease and no events, the ejection fraction (EF) with the 16-frame study was significantly higher than that with the 8-frame study by 4% only in men [19] .
Myocardial segmentation and quantification
Myocardial perfusion images of short-axis, vertical longaxis, and horizontal long-axis images were generated with a standard acquisition protocol, which had been verified by the J-ACCESS study [6, 19, 20] . All SPECT images were interpreted using a 20-segment model by experienced physicians. The use of a 20-segment model was to compare results with the precedent J-ACCESS study, which showed good correlation with a 17-segment model [21] . Each of the myocardial segments was visually scored using a 5-point scoring system: 0=normal, 1=mildly reduced, 2=moder-ately reduced, 3=severely reduced, and 4=absent. Total scores in 20 segments were calculated as the sum of stress, rest, and difference scores (SSS, SRS, and SDS). Four SSS severity categories were used for risk-based groups of 0-3 (normal), 4-8 (mild), 9-13 (moderate), and ≥14 (severe).
Procedures for quantification of gated SPECT are described elsewhere [6, 20] . Gated SPECT was analyzed by QGS software (Cedars Sinai Medical Center, Los Angeles, CA, USA) at each institution [19] . Manual adjustment was performed when automatic edge tracing was inappropriate. The left ventricular ejection fraction (LVEF, %), end-diastolic volume (EDV, ml), and endsystolic volume (ESV, ml) were obtained.
Follow-up survey
The cardiovascular events were investigated at 1, 2, and 3 years after the registration, and this interim report was based on the results of the 1-year follow-up. Follow-up was completed in 100% of the patients by the end of 1 year. After excluding 7 patients who had early revascularization <30 days after registration, 506 patients were finally selected for prognostic analysis. Events of all-cause death and nonfatal acute coronary syndrome were defined as hard events. Total events further included percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), de novo stable angina, unstable angina, severe heart failure requiring hospitalization, transient ischemic attack of the brain, stroke, and arteriosclerosis obliterans.
Statistics
Continuous variables are expressed as mean ± standard deviation (SD). We applied the Wilcoxon rank sum test to compare results from patients with and without cardiac events and the χ 2 test to categorical data. The differences in cardiovascular event rates among SSS severity groups were compared using Kaplan-Meier estimates. The independent variables in the univariate Cox proportional hazard model included age, gender, cardiac risk factors, summed scores, QGS parameters of EF, and volumes. The relative hazard ratios, 95% confidence intervals, and Wald χ 2 values were calculated. The multivariate Cox proportional model was applied using a forward stepwise method based on selected independent variables with the univariate Cox proportional hazard model. Statistical significance was defined as p<0.05.
Results
Clinical backgrounds
Among the criteria for patient registry, the criteria of IMT max ≥1.1 mm and urinary albumin excretion rate of ≥30 mg/g of creatinine were satisfied in 37 and 35% of patients, respectively. Table 1 shows patient characteristics in 506 subjects. Common risk factors were hypertension (82%) and dyslipidemia (80%). Regarding other risk factors, 17 and 26% of patients had a history of current and past smoking, respectively, and 6% had a family history of coronary artery disease (CAD). BMI of ≥30 kg/m 2 was observed in 40 patients (8%). Regarding medications, hypoglycemic drugs were most often used (83%). Coronary angiography was performed in 45 patients (9%). Coronary artery stenosis ≥75% was observed in 19 patients: single-, double-, and triple-vessel diseases in 9, 8, and 2 patients, respectively.
SPECT findings of perfusion defects and ischemia
Myocardial ischemia without fixed defects (scarring) defined as SDS ≥2 and SRS <4 was observed in 54 patients (11%), and fixed perfusion defect without ischemia defined as SRS ≥4 and SDS <2 was observed in 80 patients (16%) (Fig. 1) . Fixed perfusion defect associated with ischemia defined as SRS ≥4 and SDS ≥2 was observed in 30 patients (6%). The remaining normal findings were observed in 342 patients (68%). Stress-induced ischemia with and without scarring was observed in 84 patients (17%).
Death and cardiovascular events by the end of 1 year
During the 1-year follow-up period, six patients died, including two from sudden death, one from severe heart failure and double-vessel disease, two from cancer, and one from complications of pneumonia ( cancer patients experienced stable angina and PCI before death. Two patients who showed EF <50% had severe heart failure; one died and the other had CABG.
Regarding nonfatal cardiovascular events, de novo stable angina pectoris was diagnosed in 11 patients, 8 of whom had PCI, and the remaining patients were medically treated. Either a cerebrovascular accident or transient ischemia attack was observed in seven patients. PCI was performed in 12, CABG in 1, and both PCI and CABG in 1.
The following events were summarized based on allcause death and nonfatal cardiovascular events. Patients with and without events are compared in Table 3 . Patients with events had a significantly higher incidence of ECG abnormality at rest (p=0.02) and of significant coronary stenosis (≥75%) in at least one vessel than those without events (24 vs 2%, p=0.005). Regarding medication, in patients with events, medications for dyslipidemia were less frequent in the event group (p=0.03). Although EF and volumes did not differ significantly, patients with cardiac events showed higher SSS (p=0.005) and SDS (p=0.02). When patients with SSS ≤8 and >8 were compared, cardiac event rates were 5% for the low SSS group and 20% for the high SSS group (p=0.0002). The high SSS group showed a higher LDL cholesterol (p=0.03), a lower incidence of dyslipidemic medication (p=0.02), a higher blood urea nitrogen (p=0.04), a higher urinary albumin excretion rate (p=0.02), and a higher incidence of segmental wall motion abnormality (p=0.009). Myocardial perfusion defect scores of SRS and SDS were higher in the high SSS group (p<0.0001 for all). Higher EDV, higher ESV, and lower EF were observed in the high SSS group (p<0.0001 for all).
The Kaplan-Meier curve for the event-free survival is shown in Fig. 2 . At the end of the 1-year follow-up, the event-free rate was 0.96, 0.95, 0.82, and 0.76 for the SSS group of 0-3, 4-8, 9-13, and 14 or more, respectively. Since the curves were divided into two groups of SSS≤8 and >8 and differed significantly (p<0.0001), the following analysis was performed using two groups of high and low SSS values.
Univariate analysis showed that the significant variables were HDL cholesterol, blood urea nitrogen, creatinine, ECG abnormality at rest, significant coronary stenosis, SRS, SDS, and SSS (Fig. 3) . When the multivariate Cox regression analysis was applied, SSS (>8 vs≤8, χ 2 =16.9, p<0.0001), rest ECG abnormality (χ 2 =6.1, p=0.013), and cerebrovascular accident (χ 2 =5.7, p=0.017) were the independent predictors of cardiovascular events, but the HDL cholesterol was not selected as a significant predictor.
Discussion
In the J-ACCESS 2 population with asymptomatic type 2 diabetes, which was strictly defined by the selection criteria of carotid IMT max , microalbuminuria, abdominal obesity, dyslipidemia, and hypertension, stress-induced ischemia was observed in 17% of patients. The cardiovascular event rate was fourfold higher in high SSS patients (>8) than in low SSS (≤8) patients. The total event rate was 33 of 506 (6.5%) including 6 deaths (1.2%). Patients with events had higher SSS and SDS, ECG abnormality at rest, and significant coronary artery stenosis found by coronary angiography than those without.
Among patients with diabetes, CAD is a leading cause of death, as well as extensive deterioration of macrovascular and microvascular components of multiple organs. The prevalence of diabetes in the Japanese population, however, has been considered to be lower than that in the Western population, but it is rapidly increasing with westernizing lifestyles, as revealed by recent epidemiological surveys of Hisayama and the Japanese Diabetes Society [22] [23] [24] . Therefore, by recognizing the differences in baseline lifestyles between Western and Japanese populations, the cardiovascular event rate in Japanese asymptomatic diabetic patients was of great concern. The high prevalence of diabetes was also confirmed by the J-ACCESS study, which included 30% of diabetic patients by consecutive registration of 4,629 patients [6] . The impact of diabetes was equivalent to that of prior myocardial infarction when the major cardiac event rate of cardiac death, nonfatal myocardial infarction, and severe heart failure requiring hospitalization was analyzed. The finding in the Japanese population was in accordance with the study by Haffner et al. BMI body mass index, IMT intima-media thickness, CAD coronary artery disease, VD vessel disease, EDV end-diastolic volume, ESV end-systolic volume, LVEF left ventricular ejection fraction, SSS summed stress score, SRS summed rest score, SDS summed difference score and also consistent with a statement "diabetes is a cardiovascular disease" by the American Heart Association [5, 25] . A high incidence of abnormal scans has been noted in asymptomatic patients. Miller et al. found that abnormal scans were present in ∼60% of asymptomatic diabetic patients, approximately equal to the percentage in symptomatic diabetics [26] . In addition, the DIAD study indicated that silent myocardial ischemia occurred in as high as 22% of asymptomatic patients with type 2 diabetes [27] . In another European study involving 120 asymptomatic patients, 33% had an abnormal stress study, including myocardial perfusion abnormalities in 25% of patients [28] .
The present J-ACCESS 2 study demonstrated a relatively lower incidence (17%) of induced ischemia. This was probably caused by the differences in criteria of patient entry and partly due to baseline ethnic differences among American, European, and Japanese populations.
The incidence of ischemia and cardiovascular events is thought to be influenced by the selection criteria. Screening all diabetic patients is not justified from a practical point of view. It is imperative to identify the best candidates for screening diabetic patients to obtain the high diagnostic yield from MPI [29] . In the DIAD study, careful exclusion criteria were used to avoid the possibility of ischemic heart diseases, namely to select truly asymptomatic patients. In the J-ACCESS 2 study, to register the patients with appropriate diagnostic yields, we decided to select the patients who had the metabolic status of possible ischemia, although they had no chest symptoms and evidence of CAD at the time of entry. The DIAD study patients showed a mean HbA 1c of 7.1±1.5%, LDL cholesterol of 113±32 mg/dl, and 85% of either insulin or oral agent treatment, whereas the J-ACCESS 2 showed 7.5±1.2%, 118±31 mg/dl, and 83%, respectively. Moreover, BMI was higher in the DIAD study (31±6 kg/m 2 ) than in the J-ACCESS 2 study (25±4 kg/m 2 ). Albuminuria of >30 mg/g creatinine was observed in 21% of the patients in the DIAD study, whereas in the J-ACCESS 2 study the average albuminuria was 175±505 mg/g. The J-ACCESS 2 study demonstrated that significant predictors of cardiovascular events were defect score during Fig. 2 Event-free survival in four severity groups: SSS 0-3 (n=363), 4-8 (n=93), 9-13 (n=33), and >13 (n=17). A significant difference was observed between groups between SSS 0-8 and SSS ≥9 (p<0.0001) Fig. 3 Hazard ratios by univariate Cox regression analysis. Bars indicate the hazard ratio and 95% confidence intervals; p values <0.05 are shown stress, rest ECG abnormality, and cerebrovascular accidents by multivariate analysis. In contrast, Scholte et al. demonstrated that current smoking, duration of diabetes, and the cholesterol to HDL ratio predicted an abnormal study [28] . During their 1-year follow-up, 5% (6 of 120) had cardiac events. Although the predictors may differ between the studies, our study endpoint was cardiovascular events, not perfusion abnormality. Our study showed an event rate of 6.5% (33 of 506) comparable to this European study. In the J-ACCESS 2 population, LDL cholesterol differed between high and low SSS groups, but the event rates did not differ significantly between them. The event group, however, showed a tendency toward lower HDL cholesterol (p =0.06). Smoking was not a significant predictor for ischemia and cardiac events in this study and the preceding J-ACCESS study with regards to major cardiac events and total events [6, 15] .
The outcome of the diabetic patient with SPECT abnormality was worse than those without SPECT abnormality. A study of asymptomatic diabetic patients without known CAD demonstrated a 2.2% annual critical event rate of myocardial infarction and cardiac deaths [30] . Another study demonstrated that 8.6% of patients with diabetes had cardiac events (cardiac deaths and myocardial infarction) compared with 4.5% in the nondiabetic cohort [12] . The critical event rate seemed lower in our study as long as 1-year interim results were observed. Even in our study, however, in asymptomatic patients the incidence of sudden death, PCI, CABG, and severe heart failure was 3.6% and of cerebrovascular accident and transient ischemic attack 1.4%. Interestingly, Wackers et al. found that the majority of asymptomatic patients with type 2 diabetes demonstrated resolution of ischemia on repeat stress imaging after 3 years [31] . Therefore, appropriate or aggressive management of these patients would modify the outcome, and further follow-up has continued for 3 years in our study group.
Conclusion
When asymptomatic diabetic patients were followed up in a Japanese population, the incidence of cardiovascular events with SPECT abnormality was higher than that without SPECT abnormality even in the 1-year interim summary. To avoid potential outcome of hard events in these patients, targeted efforts would be required for those who have clinical conditions of microalbuminuria, increased carotid IMT max , dyslipidemia, hypertension, and abdominal obesity.
